Hope for progressive multifocal leukoencephalopathy
- PMID: 34302776
- DOI: 10.1016/S1474-4422(21)00206-4
Hope for progressive multifocal leukoencephalopathy
Conflict of interest statement
DBC has participated in Data Safety Monitoring Boards or Independent Data Monitoring Committees for clinical trials funded by Seattle Genetics, Arena Pharmaceuticals, Atara Biotherapeutics, Wave Life Sciences, Takeda, Sanofi, Shire, Excision Biotherapeutics, Biogen, and Roche/Genentech, outside the work commented on here.
Comment on
-
BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study.Lancet Neurol. 2021 Aug;20(8):639-652. doi: 10.1016/S1474-4422(21)00174-5. Lancet Neurol. 2021. PMID: 34302788 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources